Qiang Li1, Sei-Myoung Han1, Woo-Jin Song1, Sang-Chul Park1, Min-Ok Ryu1, Hwa-Young Youn2. 1. Department of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea. 2. Department of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea hyyoun@snu.ac.kr.
Abstract
BACKGROUND/AIM: The transcription factors Oct4 and Sox2 enhance the proliferation and pluripotency of human adipose tissue-derived mesenchymal stem cells (hAT-MSCs); however, the anti-inflammatory effects of Oct4- and Sox2-overexpressing hAT-MSCs (Oct4/Sox2-hAT-MSCs) are unclear. Here, we evaluated the anti-inflammatory effects of Oct4/Sox2-hAT-MSCs in vitro and in vivo. MATERIALS AND METHODS: Supernatants from green-fluorescent protein (GFP)- and Oct4/Sox2-hAT-MSCs were used to treat lipopolysaccharide (LPS)-stimulated RAW264.7 cells and inflammatory cytokine expression was determined. In LPS-induced mice, GFP- and Oct4/Sox2-hAT-MSCs were injected intraperitoneally and survival rates, as well as sickness scores of mice, were monitored. RESULTS: Decreased expression of pro-inflammatory cytokines was observed in Oct4/Sox2-hAT-MSC supernatant-exposed RAW264.7 cells compared to that in GFP-hAT-MSC supernatant-exposed RAW264.7 cells. The sickness score was reduced to 34.9% and the survival rate was increased by 11.1% in Oct4/Sox2-hAT-MSC-injected mice compared to that in GFP-hAT-MSC-injected mice. CONCLUSION: Our findings provide important insights into the development of therapies utilizing Oct4/Sox2-hAT-MSCs in inflammatory diseases. Copyright
BACKGROUND/AIM: The transcription factors Oct4 and Sox2 enhance the proliferation and pluripotency of human adipose tissue-derived mesenchymal stem cells (hAT-MSCs); however, the anti-inflammatory effects of Oct4- and Sox2-overexpressing hAT-MSCs (Oct4/Sox2-hAT-MSCs) are unclear. Here, we evaluated the anti-inflammatory effects of Oct4/Sox2-hAT-MSCs in vitro and in vivo. MATERIALS AND METHODS: Supernatants from green-fluorescent protein (GFP)- and Oct4/Sox2-hAT-MSCs were used to treat lipopolysaccharide (LPS)-stimulated RAW264.7 cells and inflammatory cytokine expression was determined. In LPS-induced mice, GFP- and Oct4/Sox2-hAT-MSCs were injected intraperitoneally and survival rates, as well as sickness scores of mice, were monitored. RESULTS: Decreased expression of pro-inflammatory cytokines was observed in Oct4/Sox2-hAT-MSC supernatant-exposed RAW264.7 cells compared to that in GFP-hAT-MSC supernatant-exposed RAW264.7 cells. The sickness score was reduced to 34.9% and the survival rate was increased by 11.1% in Oct4/Sox2-hAT-MSC-injected mice compared to that in GFP-hAT-MSC-injected mice. CONCLUSION: Our findings provide important insights into the development of therapies utilizing Oct4/Sox2-hAT-MSCs in inflammatory diseases. Copyright
Authors: Jianguo Xu; Charles R Woods; Ana L Mora; Robert Joodi; Kenneth L Brigham; Smita Iyer; Mauricio Rojas Journal: Am J Physiol Lung Cell Mol Physiol Date: 2007-04-06 Impact factor: 5.464
Authors: M A Clark; L D Plank; A B Connolly; S J Streat; A A Hill; R Gupta; D N Monk; A Shenkin; G L Hill Journal: Crit Care Med Date: 1998-10 Impact factor: 7.598
Authors: Hao Jia Wu; Wai Han Yiu; Rui Xi Li; Dickson W L Wong; Joseph C K Leung; Loretta Y Y Chan; Yuelin Zhang; Qizhou Lian; Miao Lin; Hung Fat Tse; Kar Neng Lai; Sydney C W Tang Journal: PLoS One Date: 2014-03-19 Impact factor: 3.240
Authors: Hyun Jung Lee; Sun-Hee Oh; Hui Won Jang; Ji-Hee Kwon; Kyoung Jin Lee; Chung Hee Kim; Soo Jung Park; Sung Pil Hong; Jae Hee Cheon; Tae Il Kim; Won Ho Kim Journal: Gut Liver Date: 2016-05-23 Impact factor: 4.519
Authors: Chiara Giacomelli; Letizia Natali; Marco Nisi; Marinella De Leo; Simona Daniele; Barbara Costa; Filippo Graziani; Mario Gabriele; Alessandra Braca; M Letizia Trincavelli; Claudia Martini Journal: Stem Cell Res Ther Date: 2018-05-11 Impact factor: 6.832